← Back to Search

Allergen Extract

SLIT of HDM allergen extracts for House Dust Mite Allergy

Phase 1
Waitlist Available
Led By Piyush Patel, MD
Research Sponsored by Stallergenes Greer
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 10 dosing treatment days
Awards & highlights

Summary

The purpose of this study is to investigate the safety and tolerability of different doses of sublingual tablets of house dust mite (HDM) allergen extracts in adolescents with house dust mite-associated allergic rhinitis.

Eligible Conditions
  • House Dust Mite Allergy

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~10 dosing treatment days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 10 dosing treatment days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Safety and tolerability evaluated on treatment emergent adverse events
Secondary outcome measures
12 lead ECG parameters
Adverse Events leading to study withdrawal
Safety laboratory testings
+2 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: SLIT of HDM allergen extractsExperimental Treatment1 Intervention
Sublingual Immunotherapy Tablets of House Dust Mite allergen extracts
Group II: Placebo Sub Lingual Immunotherapy Tablets (SLIT)Placebo Group1 Intervention
Placebo tablets Matching the HDM allergen extract Sub Lingual Immunotherapy Tablets
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
SLIT tablets of HDM allergen extracts
2013
Completed Phase 1
~40

Find a Location

Who is running the clinical trial?

Syneos HealthOTHER
174 Previous Clinical Trials
68,189 Total Patients Enrolled
Stallergenes GreerLead Sponsor
26 Previous Clinical Trials
13,163 Total Patients Enrolled
3 Trials studying House Dust Mite Allergy
2,087 Patients Enrolled for House Dust Mite Allergy
Piyush Patel, MDPrincipal InvestigatorInflamax Research Incorporated
3 Previous Clinical Trials
806 Total Patients Enrolled
~3 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top